Mar. 1 at 2:59 PM
$PMI It seems more likely that the stock has been pressured simply because of significant dilution and the long timeline remaining until potential FDA approval, which naturally makes it an easy target for selling pressure. Other explanations, such as fraud, do not appear to be the primary reason. Stocks declining by 90% are not uncommon, especially among small cap companies. I remain neutral overall, but I do not believe the company lacks potential entirely. It is also questionable whether a technology with a lineage spanning more than 40 years would simply disappear overnight.
